The data suggests that similar to cysteamine, our novel nano-formulation has the potential to rescue ΔF508-CFTR from aggresome-bodies to the PM via autophagy-induction, thus providing a strategy for increasing the levels of functional CFTR in CF lungs. The gene discussed is CFTR; the disease is cystic fibrosis.